BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8626425)

  • 1. Bcl-x(S) anatagonizes the protective effects of Bcl-x(L).
    Minn AJ; Boise LH; Thompson CB
    J Biol Chem; 1996 Mar; 271(11):6306-12. PubMed ID: 8626425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The BH3 domain of Bcl-x(S) is required for inhibition of the antiapoptotic function of Bcl-x(L).
    Chang BS; Kelekar A; Harris MH; Harlan JE; Fesik SW; Thompson CB
    Mol Cell Biol; 1999 Oct; 19(10):6673-81. PubMed ID: 10490606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL.
    Simonian PL; Grillot DA; Merino R; Nuñez G
    J Biol Chem; 1996 Sep; 271(37):22764-72. PubMed ID: 8798452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2.
    Zha H; Aimé-Sempé C; Sato T; Reed JC
    J Biol Chem; 1996 Mar; 271(13):7440-4. PubMed ID: 8631771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L).
    Inohara N; Ding L; Chen S; Núñez G
    EMBO J; 1997 Apr; 16(7):1686-94. PubMed ID: 9130713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regions outside of the Bcl-2 homology domains, BH1 and BH2 protect a dopaminergic neuronal cell line from staurosporine-induced cell death.
    Oh YJ; Uhland-Smith A; Kim JE; O'Malley KL
    Brain Res Mol Brain Res; 1997 Nov; 51(1-2):133-42. PubMed ID: 9427515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-xL regulates apoptosis by heterodimerization-dependent and -independent mechanisms.
    Minn AJ; Kettlun CS; Liang H; Kelekar A; Vander Heiden MG; Chang BS; Fesik SW; Fill M; Thompson CB
    EMBO J; 1999 Feb; 18(3):632-43. PubMed ID: 9927423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2, Bcl-x(L) and Bax oligomerization, induction of cytochrome c release, and activation of cell death.
    Shangary S; Johnson DE
    Biochemistry; 2002 Jul; 41(30):9485-95. PubMed ID: 12135371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bax-independent inhibition of apoptosis by Bcl-XL.
    Cheng EH; Levine B; Boise LH; Thompson CB; Hardwick JM
    Nature; 1996 Feb; 379(6565):554-6. PubMed ID: 8596636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl2-L-10, a novel anti-apoptotic member of the Bcl-2 family, blocks apoptosis in the mitochondria death pathway but not in the death receptor pathway.
    Zhang H; Holzgreve W; De Geyter C
    Hum Mol Genet; 2001 Oct; 10(21):2329-39. PubMed ID: 11689480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax.
    Yin XM; Oltvai ZN; Korsmeyer SJ
    Nature; 1994 May; 369(6478):321-3. PubMed ID: 8183370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2.
    Chang BS; Minn AJ; Muchmore SW; Fesik SW; Thompson CB
    EMBO J; 1997 Mar; 16(5):968-77. PubMed ID: 9118958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A splicing variant of the Bcl-2 member Bok with a truncated BH3 domain induces apoptosis but does not dimerize with antiapoptotic Bcl-2 proteins in vitro.
    Hsu SY; Hsueh AJ
    J Biol Chem; 1998 Nov; 273(46):30139-46. PubMed ID: 9804769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The BH3 domain of Bax is sufficient for interaction of Bax with itself and with other family members and it is required for induction of apoptosis.
    Simonen M; Keller H; Heim J
    Eur J Biochem; 1997 Oct; 249(1):85-91. PubMed ID: 9363757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of BFL-1 for its interaction with BAX and its anti-apoptotic action in mammalian and yeast cells.
    Zhang H; Cowan-Jacob SW; Simonen M; Greenhalf W; Heim J; Meyhack B
    J Biol Chem; 2000 Apr; 275(15):11092-9. PubMed ID: 10753914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function analysis of Bcl-2 family proteins. Regulators of programmed cell death.
    Reed JC; Zha H; Aime-Sempe C; Takayama S; Wang HG
    Adv Exp Med Biol; 1996; 406():99-112. PubMed ID: 8910675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bax- and Bak-induced cell death in the fission yeast Schizosaccharomyces pombe.
    Jürgensmeier JM; Krajewski S; Armstrong RC; Wilson GM; Oltersdorf T; Fritz LC; Reed JC; Ottilie S
    Mol Biol Cell; 1997 Feb; 8(2):325-39. PubMed ID: 9190211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bim(L) displacing Bcl-x(L) promotes Bax translocation during TNFalpha-induced apoptosis.
    Zhang L; Xing D; Chen M
    Apoptosis; 2008 Jul; 13(7):950-8. PubMed ID: 18500555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions.
    Finnegan NM; Curtin JF; Prevost G; Morgan B; Cotter TG
    Br J Cancer; 2001 Jul; 85(1):115-21. PubMed ID: 11437412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural biology of the Bcl-2 family of proteins.
    Petros AM; Olejniczak ET; Fesik SW
    Biochim Biophys Acta; 2004 Mar; 1644(2-3):83-94. PubMed ID: 14996493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.